USPTO Patent Grant: Peptides for Treating Glioma Tumors
Summary
The USPTO has granted patent US12582695B2 for peptides, compositions, and methods to treat glioma tumors infiltrated with macrophages. The patent was filed on November 27, 2019, and is assigned to Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polska Akademia Nauk.
What changed
The United States Patent and Trademark Office (USPTO) has issued patent US12582695B2, titled 'Peptides for treating glioma tumors infiltrated with macrophages.' This patent covers isolated peptides, compositions containing them, and methods for treating macrophage-infiltrated tumors, specifically glioblastomas. The patent was filed on November 27, 2019, by Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polska Akademia Nauk and includes 21 claims.
This is a grant of intellectual property and does not impose new regulatory obligations on companies. However, it signifies exclusive rights for the assignee in the claimed therapeutic area, which may impact competitors or potential licensees in the pharmaceutical and biotechnology sectors. Compliance officers should note this as a development in the competitive landscape for glioma treatments.
Archived snapshot
Mar 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Compositions and methods for treating glioma
Grant US12582695B2 Kind: B2 Mar 24, 2026
Assignee
Instytut Biologii Doświadczalnej im. Marcelego Nenckiego Polska Akademia Nauk
Inventors
Bozena Kaminska-Kaczmarek, Aleksandra Ellert-Miklaszewska, Katarzyna Poleszak, Maria Pasierbinska, Pawel Wisniewski
Abstract
The present invention is directed to isolated peptides, compositions comprising same and methods of use thereof for treating tumors infiltrated with macrophages, such as glioblastomas.
CPC Classifications
A61K 38/10 A61K 38/00 A61P 35/00 C07K 14/535 C07K 7/08
Filing Date
2019-11-27
Application No.
17298285
Claims
21
Named provisions
Related changes
Get daily alerts for USPTO Patent Grants - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.